Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Pegylated carboxyhaemoglobin

EU orphan designation number: EU/3/09/698   
Active ingredient: Pegylated carboxyhaemoglobin
Indication: Treatment of sickle cell disease
Sponsor: Voisin Consulting S.A.R.L.
3 rue des Longs Prés, F-92100 Boulogne-Billancourt, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
02/12/2009 Orphan designation EMEA/OD/075/09 (2009)9605 of 26/11/2009